Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

BBI Pharmaceuticals to fund phase I trial with soybean extract in BPH

March 14, 1997

Positive phase III results for GelTex's RenaGel

March 12, 1997

Roussel Uclaf reports agents for BPH

March 11, 1997

New selective alpha1a/A-antagonist from Abbott

March 10, 1997

Pharmacokinetic-pharmacodynamic interactions between terazosin and finasteride

March 3, 1997

Agents for urinary incontinence from Nippon Shinyaku

Feb. 28, 1997

Positive clinical results for doxazosin as BPH Rx

Feb. 21, 1997

Agents for BPH disclosed by Merck & Co.

Feb. 19, 1997

Natural 5alpha-reductase inhibitors discovered at Taisho

Feb. 10, 1997

Dual-action compounds for BPH described by Zeria

Feb. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...